Xia Yu, director at Summit Therapeutics, buys $9.9 million in shares
Gamco Investors, Inc. ET AL reported the sale of 800 shares of Tredegar Corp NASDAQ:TG common stock on September 24, 2025. The shares were sold at a price of $8.0245, for a total transaction value of $6419. The transaction occurred near the stock’s current trading level of $7.91, with Tredegar maintaining a market capitalization of $271 million. According to InvestingPro analysis, the company currently shows a FAIR financial health score.
Following the transaction, the number of shares owned indirectly by Investment Partnership I is 2200.
The filing also indicates that Associated Capital Group, Inc. directly owns 4000 shares of Tredegar Corp . common stock. Another 4000 shares are indirectly owned by Investment Partnership II, and 300 by Investment Partnership III.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
